|
|
Article: Longitude Capital Closes $325 Million Life Sciences Fund.
- Article from:
- PR Newswire
- Article date:
- July 8, 2008
CopyrightCOPYRIGHT 2008 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Longitude Focusing on Medical Device and Biotechnology Companies
MENLO PARK, Calif., July 8 /PRNewswire/ -- Longitude Capital today announced the closing of its first investment vehicle, Longitude Venture Partners, L.P. (the "Fund"), a $325 million venture capital fund dedicated to life sciences investments. The Fund exceeded its target of $250 million.
The team at Longitude Capital includes: Managing Directors Juliet Tammenoms Bakker, Patrick Enright and Marc-Henri Galletti, Venture Partner Jeffrey Gold, Principals Douglas Foster and David Hirsch, and CFO Elaine Erickson. The firm was formed following the team's spin-out from Pequot Capital, where ...